Cannabis sativa (Vijaya) in Wound Healing: A Systematic Review of Preclinical and Clinical Evidence
International Journal of Drug Delivery Technology · 25.05.2026 · 16 (32s)
DOI: 10.25258/ijddt.16.32s.83 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 25.05.2026. Verfasst von Divya Deepak Patil und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Themen: Wundversorgung
Abstract (Originalsprache)
Background
In Ayurveda, Cannabis sativa L., traditionally known as Vijaya, has been recognized for its wound healing properties. Despite growing biomedical interest in cannabinoids, no prior review has comprehensively integrated both preclinical and clinical evidence regarding its role in tissue repair. This systematic review synthesizes both preclinical and clinical evidence concerning its efficacy in facilitating wound healing.
Methods
In accordance with the PRISMA 2020 guidelines, we conducted a search across several databases, including CINAHL, Cochrane Library, Medline, Embase, PubMed, Web of Science, and LILACS, up until March 2026. The studies considered involved both animals and humans and focused on the use of Cannabis sativa or cannabinoids for healing integumentary wounds. The quality of these studies was evaluated using SYRCLE's RoB tool and JBI checklists.
Results
A total of eighteen studies were reviewed, comprising 11 animal studies and 7 human studies. In rats, the application of topical hemp fruit oil extract resulted in complete wound closure by the 20th day. Hydrogels containing CBD facilitated granulation, collagen formation, and the development of new blood vessels. Among human participants (n=92), chronic wounds that were previously non-healing closed in an average of 54 days when treated with either oral or topical cannabinoids. On a mechanistic level, cannabinoids are known to inhibit NF-kB, decrease oxidative stress, and exhibit antibacterial properties. The quality of animal studies ranged from moderate to high risk of bias, while evidence from human studies is still limited.
Conclusion
Although preclinical studies indicate that Cannabis sativa may aid in wound healing, there is a lack of high-quality clinical trials to confirm this. Cannabinoid-based wound therapeutics represent a promising translational field; however, rigorous randomized controlled trials, standardized formulations, and long-term safety data are urgently required.
Zitieren
APA
Patil, D. D., & Kadam, S. (2026). Cannabis sativa (Vijaya) in Wound Healing: A Systematic Review of Preclinical and Clinical Evidence. International Journal of Drug Delivery Technology, 16(32s). https://doi.org/10.25258/ijddt.16.32s.83
Vancouver
Patil DD, Kadam S. Cannabis sativa (Vijaya) in Wound Healing: A Systematic Review of Preclinical and Clinical Evidence. International Journal of Drug Delivery Technology. 2026;16(32s). doi:10.25258/ijddt.16.32s.83
BibTeX
@article{Patil2026,
author = {Patil, Divya Deepak and Kadam, Sujata},
title = {Cannabis sativa (Vijaya) in Wound Healing: A Systematic Review of Preclinical and Clinical Evidence},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {32s},
doi = {10.25258/ijddt.16.32s.83}
}
EUVIMED